BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Penn Epigenetics - ECPv6.18.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Penn Epigenetics
X-ORIGINAL-URL:https://epigenetics.upenndev.pendari.com
X-WR-CALDESC:Events for Penn Epigenetics
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251009T160000
DTEND;TZID=America/New_York:20251009T170000
DTSTAMP:20250725T152831Z
CREATED:20250725T152831Z
LAST-MODIFIED:20250725T152831Z
UID:13938-1760025600-1760029200@epigenetics.upenndev.pendari.com
SUMMARY:Chris Hartl\, Ph.D. (Epigenome Technologies) || Special Seminar
DESCRIPTION:We are pleased to welcome Chris Hartl\, PhD\, Chief Technology Officer at Epigenome Technologies for a Special Seminar. Dr. Hartl will present an update on the company’s latest news and innovations and how they can work with you to enhance your research. \nChristopher Hartl\, Ph.D. is Chief Technology Officer at Epigenome Technologies\, where he leads the development of scalable single-cell and spatial epigenomics products. He brings over 15 years of experience building high-performance computational tools and bioinformatics platforms across both academic genomics and commercial biotech. At the Broad Institute\, he helped develop foundational methods in variant detection and large-scale genomic analysis. At Rancho Biosciences\, he led product development for multi-omic integration\, clinical data modeling\, and AI-powered target discovery. His work spans algorithm design\, machine learning\, and cloud-scale analytics\, with a focus on turning complex biological data into usable insight. Chris holds a Ph.D. in Bioinformatics from UCLA\, where his research combined epigenetics\, transcriptomics\, and systems biology to study gene regulation in neurodevelopmental disorders.
URL:https://epigenetics.upenndev.pendari.com/event/chris-hartl-ph-d-epigenome-technologies-special-seminar/
ATTACH;FMTTYPE=image/jpeg:https://epigenetics.upenndev.pendari.com/wp-content/uploads/2025/07/Picture1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251009T160000
DTEND;TZID=America/New_York:20251009T170000
DTSTAMP:20250725T152831Z
CREATED:20250725T152831Z
LAST-MODIFIED:20250725T152831Z
UID:14793-1760025600-1760029200@epigenetics.upenndev.pendari.com
SUMMARY:Chris Hartl\, Ph.D. (Epigenome Technologies) || Special Seminar
DESCRIPTION:We are pleased to welcome Chris Hartl\, PhD\, Chief Technology Officer at Epigenome Technologies for a Special Seminar. Dr. Hartl will present an update on the company’s latest news and innovations and how they can work with you to enhance your research. \nChristopher Hartl\, Ph.D. is Chief Technology Officer at Epigenome Technologies\, where he leads the development of scalable single-cell and spatial epigenomics products. He brings over 15 years of experience building high-performance computational tools and bioinformatics platforms across both academic genomics and commercial biotech. At the Broad Institute\, he helped develop foundational methods in variant detection and large-scale genomic analysis. At Rancho Biosciences\, he led product development for multi-omic integration\, clinical data modeling\, and AI-powered target discovery. His work spans algorithm design\, machine learning\, and cloud-scale analytics\, with a focus on turning complex biological data into usable insight. Chris holds a Ph.D. in Bioinformatics from UCLA\, where his research combined epigenetics\, transcriptomics\, and systems biology to study gene regulation in neurodevelopmental disorders.
URL:https://epigenetics.upenndev.pendari.com/event/chris-hartl-ph-d-epigenome-technologies-special-seminar-2/
ATTACH;FMTTYPE=image/jpeg:https://epigenetics.upenndev.pendari.com/wp-content/uploads/2025/07/Picture1.jpg
END:VEVENT
END:VCALENDAR